TERRY WHITE CHEMISTS RISEDRONATE/Ca 35/1250 risedronate sodium 35 mg tablet and calcium carbonate 1250 mg tablet composite blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

risedronate sodium, Quantity: 35 mg

Disponible desde:

Arrotex Pharmaceuticals Pty Ltd

Designación común internacional (DCI):

Risedronate sodium

formulario farmacéutico:

Tablet, film coated

Composición:

Excipient Ingredients: lactose; macrogol 8000; colloidal anhydrous silica; titanium dioxide; magnesium stearate; hypromellose; iron oxide red; iron oxide yellow; crospovidone; hyprolose

Vía de administración:

Oral

Unidades en paquete:

Pack sizes of 7, 14, 28, 84, 112 tablets per pack

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Treatment of osteoporosis.,Treatment of glucocorticoid-induced osteoporosis. ,Preservation of bone mineral density in patients on long term corticosteroid therapy

Resumen del producto:

Visual Identification: Risedronate tablets are orange round biconvex coated tablets engraved APO on one side RIS above 35 on the other side; Container Type: Multiple containers; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Estado de Autorización:

Licence status A

Fecha de autorización:

2012-04-13